Location History:
- Hatfield, MA (US) (1997)
- Amherst, MA (US) (1998)
Company Filing History:
2 out of 3,688 
2 out of 1,556 
1 out of 2 Years Active: 1997-1998
Title: The Innovative Contributions of Alex Bruce MacDonald
Introduction
Alex Bruce MacDonald is a notable inventor based in Amherst, MA (US). He has made significant contributions to the field of immunology, particularly in the development of vaccines and diagnostic methods for chlamydia. With a total of 3 patents to his name, MacDonald continues to influence the scientific community through his innovative work.
Latest Patents
One of MacDonald's latest patents is titled "Vaccine comprising anti-idiotypic antibody to chlamydia GLXA and process." This patent describes a genus-specific chlamydia vaccine that includes an anti-idiotype antibody capable of inducing an anti-anti-idiotypic antibody in animals. This antibody recognizes a glycoplipid exoantigen (GLXA) of chlamydia. The vaccine is produced by generating an idiotypic antibody to GLXA, which is then used to create the anti-idiotypic antibody that comprises the vaccine. Another significant patent is the "Method for diagnosing a patient for chlamydia." This method involves detecting chlamydia in an extracellular sample by contacting the sample with an idiotypic antibody to GLXA to form an immunocomplex, which is then detected.
Career Highlights
Throughout his career, MacDonald has worked with prestigious institutions such as Johns Hopkins University and the University of Massachusetts. His work at these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of MacDonald's notable coworkers include Judith A Whittum-Hudson and Elizabeth S Stuart. Their collaborative efforts have further advanced the research and development of innovative solutions in immunology.
Conclusion
Alex Bruce MacDonald is a distinguished inventor whose work in vaccine development and diagnostic methods has made a lasting impact on the field of immunology. His innovative patents and collaborations with esteemed institutions highlight his commitment to advancing scientific knowledge and improving public health.